Mario Bernhard

Author Correction: Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.

Authors:

Eline Pecho-Vrieseling Claus Rieker Sascha Fuchs Dorothee Bleckmann Maria Soledad Esposito Paolo Botta Chris Goldstein Mario Bernhard Ivan Galimberti Matthias Müller Andreas Lüthi Silvia Arber Tewis Bouwmeester Herman van der Putten Francesco Paolo Di Giorgio

Nat Neurosci 2018 Sep;21(9):1291

Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF

September 2018

X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.

ChemMedChem 2018 09 16;13(18):1997-2007. Epub 2018 Aug 16.

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.

View Article and Find Full Text PDF

September 2018

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency.

Science 2016 Mar 4;351(6278):1199-203. Epub 2016 Feb 4.

Developmental Molecular Pathways, Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF

March 2016

Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.

Authors:

Eline Pecho-Vrieseling Claus Rieker Sascha Fuchs Dorothee Bleckmann Maria Soledad Esposito Paolo Botta Chris Goldstein Mario Bernhard Ivan Galimberti Matthias Müller Andreas Lüthi Silvia Arber Tewis Bouwmeester Herman van der Putten Francesco Paolo Di Giorgio

Nat Neurosci 2014 Aug 13;17(8):1064-72. Epub 2014 Jul 13.

Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF

August 2014

Atg4b-dependent autophagic flux alleviates Huntington's disease progression.

Authors:

Catia C Proenca Natacha Stoehr Mario Bernhard Shanon Seger Christel Genoud Ana Roscic Paolo Paganetti Shanming Liu Leon O Murphy Rainer Kuhn Tewis Bouwmeester Ivan Galimberti

PLoS One 2013 8;8(7):e68357. Epub 2013 Jul 8.

Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF

February 2014

Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.

Authors:

Henk-Jan Schuurman Klaus Menninger Maxime Audet Adrien Kunkler Claudine Maurer Corinne Vedrine Mario Bernhard Lorrie Gaschen Volker Brinkmann Valerie Quesniaux

Transplantation 2002 Oct;74(7):951-60

Transplantation Research, Novartis Pharma AG, Basel, Switzerland. Presently, Immerge BioTherapeutics, Charlestown, MA 02129, USA.

View Article and Find Full Text PDF

October 2002

Publications by authors named "Mario Bernhard"

Author Correction: Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.

Authors:

X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.

Authors:

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency.

Authors:

Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.

Authors:

Atg4b-dependent autophagic flux alleviates Huntington's disease progression.

Authors:

Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.

Authors: